As Trump targets copper and medicines with sky-high duties, India’s export ambitions face a critical test—and a potentially devastating blow.
Donald Trump’s economic warpath is back in full swing, and this time, India might be in the direct line of fire. The latest salvo from the former and possibly future U.S. president includes a sweeping proposal for punitive tariffs that could redefine trade relations—and not in India’s favor.
On Tuesday, Trump announced that pharmaceuticals, one of India's biggest exports to the United States, could soon face tariffs as high as 200 percent. Copper, another vital export, is also on the chopping block, with a proposed 50 percent duty. Combined with his increasingly hostile rhetoric toward the BRICS bloc, which India is part of, these moves suggest that Trump’s economic nationalism is entering a more aggressive phase—one that could leave India scrambling.
The Pharma Sector: A High-Stakes Target
India's pharmaceutical industry is more than just a cornerstone of its economy—it’s a lifeline for millions of Americans. In 2024–25, the U.S. imported nearly $9.8 billion worth of Indian-made medicines, making it the largest buyer of Indian pharma. With manufacturing hubs in states like Telangana and Himachal Pradesh, the industry also supports hundreds of thousands of jobs back home.
But Trump’s warning is clear. If non-U.S. companies “don’t get their act together,” he said, they’ll be facing tariffs “at a very, very high rate.” The implication? That these pharmaceutical exports are a threat to American self-reliance—or worse, a pawn in a broader political game.
The irony, of course, is that American healthcare relies heavily on affordable, high-quality drugs from Indian manufacturers. Slapping a 200 percent tariff on these imports won’t create local capacity overnight—it will likely just increase costs for American patients and exacerbate drug shortages.
But nuance has never been Trump’s strong suit.
Copper Crunch: An Industrial Casualty
Then there’s copper, which sits quietly behind the scenes of every major technological and infrastructural breakthrough—from electric vehicles to power grids. India exported $2 billion worth of the metal in 2024–25, with the U.S. accounting for $360 million of that total.
Trump’s proposed 50 percent tariff on copper may not attract as many headlines as the pharma hikes, but the impact could be just as painful. India’s industrial ecosystem could see lower demand and reduced margins, while U.S. importers might start looking elsewhere—or simply pay more.
At a time when both countries are navigating complex energy transitions and digital transformations, this feels like a self-inflicted wound on economic cooperation.
Trade Deal or Trade Trap?
India remains “hopeful,” according to reports, that a bilateral trade deal can soften the blow of Trump’s tariff barrage. Negotiations have reportedly been underway for several weeks, but hope and strategy are not the same thing.
With Trump’s administration increasingly portraying BRICS as an adversarial force—accusing it of trying to “degenerate the dollar”—India finds itself in a precarious position. Can it negotiate fair terms while still aligning with BRICS? Or will it be forced to choose sides in an increasingly polarized world economy?
The 10 percent blanket tariff on all BRICS countries adds another layer of difficulty. Though it sounds like a flat charge, the symbolic damage is enormous. It rebrands a multilateral effort for financial autonomy and cooperation as something inherently anti-American.
That’s a troubling precedent—and a dangerous oversimplification.
America First, Everyone Else Last?
Trump’s aggressive tariff talk isn’t new, but the stakes are getting higher. The world is no longer in the same place it was in 2018 when trade wars were waged with China. The post-pandemic supply chain landscape is more fragile, inflationary pressures are more complex, and geopolitical alliances have shifted.
In this context, punishing India—a strategic partner in both defense and democracy—seems counterproductive at best, reckless at worst.
Yes, Trump’s rhetoric plays well to certain voter blocs. It’s red meat for the “America First” base. But policy built on applause lines rather than economic logic can do lasting damage. Alienating India, a country that has long balanced its interests carefully between East and West, might be an expensive gamble.
The Bigger Picture: A Partnership at Risk
India and the U.S. have spent years building what many hoped would be a reliable, mutually beneficial economic relationship. That work now stands at risk. If these tariffs materialize, India won’t just lose revenue—it may also lose trust in a partner that increasingly sees trade not as collaboration, but coercion.
The question isn’t just whether India can weather the tariffs. It’s whether the strategic partnership can survive the politics.
Because when every transaction becomes a threat, and every ally a potential enemy, the damage goes far beyond dollars. It strikes at the heart of diplomacy.
And in Trump’s tariff-happy world, it seems diplomacy has a price tag too.